Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Approaches To Therapy Escalation In T2D
Condition:   Type2 Diabetes
Interventions:   Drug: DPP-4 inhibitor;   Drug: SGLT2 inhibitor;   Drug: SGLT2 inhibitor and DPP-4 inhibitor
Sponsors:   LMC Diabetes & Endocrinology Ltd.;   Merck Sharp & Dohme Corp.;   Syreon Corporation
Not yet recruiting

Wed, 23 Jan 2019 12:00:00 EST


Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support
Conditions:   Diabetes Mellitus;   High Blood Pressure;   High Blood Sugar;   Hypertension
Interventions:   Behavioral: FAM ACT;   Behavioral: I-DSME+CM
Sponsors:   University of Pittsburgh;   The Community Health and Social Services Center, Inc.;   University of Michigan;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Wed, 23 Jan 2019 12:00:00 EST


Sleep-Disordered Breathing in Patients With Severe Valvular Regurgitation Undergoing Clip Procedure
Conditions:   Sleep Disordered Breathing;   Valvular Regurgitation
Intervention:  
Sponsor:   Heart and Diabetes Center North-Rhine Westfalia
Recruiting

Wed, 23 Jan 2019 12:00:00 EST


Vitamin D Treatment of Diabetic Patients With Foot Ulcers
Conditions:   Diabetic Foot Ulcers;   Vitamin D Deficiency
Interventions:   Dietary Supplement: Vitamin D;   Dietary Supplement: Placebo
Sponsor:   Zealand University Hospital
Completed

Wed, 23 Jan 2019 12:00:00 EST


A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus
Conditions:   Weight Loss;   Pediatric Obesity
Interventions:   Behavioral: Standard Care;   Behavioral: By Design;   Behavioral: Dyad Plus
Sponsors:   Wake Forest University Health Sciences;   National Institutes of Health (NIH)
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: No treatment given
Sponsor:   Novo Nordisk A/S
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


China Diabetes Registry by Metabolic Management Center
Conditions:   Type 2 Diabetes Mellitus;   Type1 Diabetes Mellitus;   Monogenetic Diabetes;   Pancreatogenic Diabetes;   Drug-Induced Diabetes Mellitus;   Other Forms of Diabetes Mellitus
Intervention:   Other: Standard diabetes management model in each MMC center
Sponsor:   Guang Ning
Recruiting

Mon, 21 Jan 2019 12:00:00 EST


Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: Fasting Mimicking diet
Sponsors:   Leiden University Medical Center;   Dutch Diabetes Research Foundation;   Health Holland;   IFOM, The FIRC Institute of Molecular Oncology;   L-Nutra
Recruiting

Mon, 21 Jan 2019 12:00:00 EST


FES Cycling and Nutritional Counseling for Battling Obesity After SCI
Condition:   Spinal Cord Injuries
Interventions:   Combination Product: HIIT-FES Cycling combined with Nutritional Counseling;   Other: Nutritional Counseling Only
Sponsors:   William Carey University;   University of Southern Mississippi;   University of Mississippi Medical Center
Recruiting

Mon, 21 Jan 2019 12:00:00 EST


Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Walking football exercise program
Sponsors:   Universidade do Porto;   Federação Portuguesa de Futebol, Portugal;   Administração Regional de Saúde do Norte, Portugal;   Fédération Internationale de Football Association
Active, not recruiting

Mon, 21 Jan 2019 12:00:00 EST


Fecal Incontinence Treatment (FIT) Study
Conditions:   Fecal Incontinence;   Bowel Incontinence
Interventions:   Behavioral: Biofeedback;   Procedure: Sacral Nerve Stimulation;   Device: Injection
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Mayo Clinic;   Colon and Rectal Surgery Associates, Ltd.;   Augusta University;   RTI International
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


Janagliflozin Treat T2DM Monotherapy
Condition:   Diabetes Type 2
Interventions:   Drug: Janagliflozin 25mg;   Drug: Janagliflozin 50mg;   Drug: Placebo/Janagliflozin
Sponsor:   Sihuan Pharmaceutical Holdings Group Ltd.
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
Condition:   Overweight or Obesity
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting

Mon, 21 Jan 2019 12:00:00 EST


Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
Conditions:   Diabetes Mellitus, Type 1;   Depressive Symptoms;   Stress, Psychological;   Glucose, High Blood
Intervention:  
Sponsors:   Norbert Hermanns;   German Center for Diabetes Research;   University of Giessen;   Helmholtz Zentrum München
Active, not recruiting

Mon, 21 Jan 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as <em>Mycoplasma genitalium</em>
FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium

Wed, 23 Jan 2019 15:51:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices
FDA takes more steps toward strengthening 510(k) program for premarket review of medical devices

Tue, 22 Jan 2019 10:50:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
FDA describes unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

Thu, 17 Jan 2019 12:56:00 -0500


FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy
FDA approved the first generic version of Sabril for treating complex partial seizures, as an adjunctive therapy in certain patients.

Wed, 16 Jan 2019 12:51:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
FDA describes new policies to advance development of safe and effective cell and gene therapies

Tue, 15 Jan 2019 12:23:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
FDA issues three documents that launch next phase of Pre-Cert Pilot Program to test new approaches for the review of digital health device applications.

Mon, 07 Jan 2019 12:27:00 -0500


FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
The FDA authorized use of a new test that measures nutrients in breast milk providing healthcare professionals with tool to aid in the nutritional management of newborns.

Fri, 21 Dec 2018 14:20:00 -0500


FDA approves new treatment for adult patients with rare, life-threatening blood disease
The FDA approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

Fri, 21 Dec 2018 10:37:00 -0500


FDA approves first treatment for rare blood disease
The FDA approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.

Fri, 21 Dec 2018 10:29:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds
Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Thu, 20 Dec 2018 16:35:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News